Microneedle Dermal Patch for Multi-Time Biomarker Sensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for monitoring biomarkers are invasive, cumbersome, and suffer from low sensitivity and specificity, making it difficult to monitor biomarker levels over time, especially in small volumes of physiological samples.

Innovation Solution

A dermal patch with sensing units, microneedles, and selector devices for collecting and analyzing physiological samples, incorporating processing reagents and buffers, and electronic circuitry for signal processing, allowing discrete measurements at multiple times.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional invasive methods (blood drawing) are used for biomarker monitoring, then measurement capability is achieved, but patient comfort deteriorates and cooperation decreases

Engineering Contradiction:
Improvebiomarker detection capabilityVSAvoidpatient discomfort and pain
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent employs a dermal patch with a flexible substrate that conforms to the skin surface, enabling non-invasive or minimally invasive analyte collection. The thin film structure allows close contact with the skin while housing sensing elements, thereby eliminating the need for needle-based blood draws and reducing patient discomfort while maintaining measurement capability.

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The patent introduces an intermediary sampling mechanism (e.g., microneedles, sweat collection layers, or interstitial fluid access) that mediates between the invasive blood draw and non-invasive monitoring. This intermediary allows analyte collection from less painful sources (such as interstitial fluid or sweat) that still provide sufficient biomarker information, thus reducing patient discomfort while preserving detection accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If conventional applicators are used for analyte monitoring, then continuous monitoring is achieved, but sensitivity and specificity deteriorate

Engineering Contradiction:
Improvecontinuous monitoring capabilityVSAvoiddetection sensitivity and specificity
Core Design Contradiction:
Duration of action of moving objectVSMeasurement precision

Solution Approach 1:

The patent divides the sensing system into multiple discrete sensing units or zones on the patch, each potentially targeting different analytes or providing redundant measurement. This segmentation allows for specialized detection mechanisms in each zone, improving overall sensitivity and specificity while maintaining continuous monitoring through aggregation of signals from multiple units.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent designs the dermal patch with multi-functional sensing capabilities that can detect multiple types of analytes (glucose, lactate, pH, etc.) simultaneously using integrated sensing elements. This multi-functionality allows a single device to provide continuous monitoring with high sensitivity and specificity across multiple biomarkers, eliminating the need for separate conventional applicators for each analyte.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If multiple sensing units are integrated in a single patch, then monitoring versatility is improved, but device complexity increases

Engineering Contradiction:
Improvemulti-analyte detection capabilityVSAvoidpatch structural complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent combines multiple sensing units, reagent reservoirs, and electronic components into a single integrated dermal patch structure. By merging these elements onto one flexible substrate with shared fluidic channels and power sources, the device achieves multi-analyte detection capability while controlling overall complexity through systematic integration rather than separate components.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent employs a nested architecture where smaller functional elements (sensing zones, micro-reservoirs, conductive traces) are embedded within layers of the patch structure. This nesting approach allows multiple sensing units to be packaged in a compact arrangement, improving versatility while minimizing the increase in device complexity through efficient spatial organization.

Inventive Principle:
Principle #7Nested doll (Nesting)

Data Source

PatentUS20260096754A1Self-contained dermal patch for detection of physiological analytes
Publication Date: 2026.04.09 SATIO INC
  • US20260096754A1 patent drawing
  • US20260096754A1 patent drawing
  • US20260096754A1 patent drawing

AI summary

In one aspect, a dermal patch is disclosed, which comprises at least a pair of sensing units each configured for detecting at least one analyte in a physiological sample, at least one microneedle configured for puncturing the skin to allow collection of the physiological sample, and a selector device for selecting any one of said sensing units for receiving at least a portion of said collected physiological sample for analysis thereof.